Prestige Consumer Healthcare (PBH) Net Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted Net Margin of 16.47% for Q4 2025, up 6.98% on a QoQ basis from 15.4% in Q3 2025, and down 455.0% year-over-year from 4.64% in Q4 2024.
Analysis
Prestige Consumer Healthcare (PBH) Net Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare has reported Net Margin for 16 years, with the latest figure at 16.47% in Q4 2025.
- On a quarterly basis, Net Margin fell 455.0% year-over-year to 16.47% in Q4 2025; TTM through Dec 2025 was 16.9%, a 223.0% decrease from a year earlier, with the FY2025 full-year figure at 18.86%, up 26.0% from the prior year.
- Net Margin was 16.47% for Q4 2025 at Prestige Consumer Healthcare, up from 15.4% in the prior quarter.
- The five-year high for Net Margin was 21.46% in Q2 2021, with the low at 84.15% in Q1 2023.
- Average Net Margin over 5 years is 13.18%, with a median of 18.54% recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Net Margin sank 10366 bps in 2023, then jumped 10200 bps in 2024.
- Over 5 years, Net Margin stood at 18.3% in 2021, then rose by 3 bps to 18.86% in 2022, then dropped by 0 bps to 18.76% in 2023, then gained by 12 bps to 21.02% in 2024, then dropped by 22 bps to 16.47% in 2025.
- The last three Net Margin figures came in at 16.47% (Q4 2025), 15.4% (Q3 2025), and 19.02% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 13.41% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 11.53% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 7.04% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 7.79% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 7.27% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -2.00% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 2.40% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 604.06 Mn | 498.16 Mn | 40.36 Mn | 12.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 16.47% |
| Sep 30, 2025 | 15.40% |
| Jun 30, 2025 | 19.02% |
| Mar 31, 2025 | 16.91% |
| Dec 31, 2024 | 21.02% |
| Sep 30, 2024 | 19.16% |
| Jun 30, 2024 | 18.37% |
| Mar 31, 2024 | 17.86% |
| Dec 31, 2023 | 18.76% |
| Sep 30, 2023 | 18.71% |
| Jun 30, 2023 | 19.07% |
| Mar 31, 2023 | -84.15% |
| Dec 31, 2022 | 18.86% |
| Sep 30, 2022 | 17.64% |
| Jun 30, 2022 | 19.95% |
| Mar 31, 2022 | 19.51% |
| Dec 31, 2021 | 18.30% |
| Sep 30, 2021 | 16.41% |
| Jun 30, 2021 | 21.46% |
| Mar 31, 2021 | 14.94% |